HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias.

Abstract
The efficacy and safety of sotalol therapy for ventricular arrhythmias was evaluated in 133 patients with drug-refractory ventricular arrhythmias. All patients had baseline electrophysiologic studies before and after oral sotalol therapy. Sixty-six patients were discharged home, treated with sotalol (52 patients without inducible ventricular tachycardia or fibrillation and 14 patients with hemodynamically stable inducible ventricular tachycardia). The mean follow-up period was 41 +/- 27 months for the 14 patients with hemodynamically stable ventricular tachycardia. Sotalol was effective in 8 of these 14 patients. Recurrent nonlethal ventricular tachycardia occurred in 3 patients; 2 patients had sudden death; and 1 patient had adverse side effects. The 52 patients without inducible ventricular tachycardia were followed up for a mean period of 36 +/- 30 months. Thirty-five of 52 patients were successfully treated. Two patients had recurrent ventricular tachycardia; both of these episodes of ventricular tachycardia occurred within the first year. Four patients had sudden cardiac death; three of these deaths occurred within the first month, and the last episode of sudden death occurred after 8 years of sotalol therapy. The actuarial incidence of sotalol efficacy was 76% at 1 year, 72% at 2 years, 64% at 4 years, and 52% at 5 years. Approximately 46% of patients receiving long-term sotalol treatment reported side effects. Side effects severe enough to warrant withdrawal of sotalol occurred in 7 (11%) patients. The results of our study suggest that sotalol is effective for selected patients with drug refractory ventricular arrhythmias. Although the incidence of side effects are high, patients appear to tolerate long-term sotalol therapy well.
AuthorsR J Lee, M Wong, A Siu, M Namekawa-Wong, L M Epstein, A P Fitzpatrick, H R Grogin, M M Scheinman, M D Lesh
JournalAmerican heart journal (Am Heart J) Vol. 132 Issue 5 Pg. 973-8 (Nov 1996) ISSN: 0002-8703 [Print] United States
PMID8892770 (Publication Type: Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Sotalol
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Arrhythmia Agents (therapeutic use)
  • Arrhythmias, Cardiac (drug therapy, physiopathology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Sotalol (therapeutic use)
  • Tachycardia, Ventricular (drug therapy, physiopathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: